Johns Hopkins Rheumatology

Home / RheumTV / Biologic Medications and Cancer Risk

Biologic Medications and Cancer Risk

By

There has been some speculation on whether or not biologic medications can increase a patient’s risk of getting cancer in the long run. Dr. Laura Cappelli from the Arthritis Center discusses these risks as well as the research studies behind them.

[arve url=”https://vimeo.com/224534856″ title=”Biologic Medications and Cancer Risk” description=”There has been some speculation on whether or not biologic medications can increase a patient’s risk of getting cancer in the long run. Dr. Laura Cappelli from the Arthritis Center discusses these risks as well as the research studies behind them.” /]

Johns Hopkins Rheumatology

The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.